| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 02/17/2000 | CA2339368A1 Inhibitors of type 3 3.alpha.-hydroxysteroid dehydrogenase |
| 02/16/2000 | EP0979653A1 Remedy for chronic fatigue syndrome |
| 02/15/2000 | US6025347 Steroid esters useful against skin disorders |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/09/2000 | EP0977578A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 02/03/2000 | WO2000005242A1 Dehydroepiandrosterone derivatives for prophylaxis and treatment of osteoporosis |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/19/2000 | EP0746322B1 Treatment of alzheimer's disease with delta5-androstenes |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/18/2000 | US6015821 Skin, psychological and cardiovascular disorders; anticarcinogenic, antiinflammatory and antidiabetic agents |
| 01/18/2000 | US6015806 Topical use in the treatment of androgen-dependent diseases associated with the skin. |
| 01/12/2000 | EP0970103A1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 01/11/2000 | CA2065311C Solid matrix system for transdermal drug delivery |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 12/29/1999 | WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067271A1 Testosterone derivative |
| 12/29/1999 | WO1999067270A1 Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone) |
| 12/29/1999 | EP0966288A1 Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 12/29/1999 | CN1239967A 8(9)-dehydroestradiol derivatives |
| 12/29/1999 | CN1239893A Hormonal composition consisting of oestrogen compound and progestational compound |
| 12/29/1999 | CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/22/1999 | EP0515386B1 Glycoalkaloids |
| 12/16/1999 | WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL |
| 12/09/1999 | WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES |
| 12/07/1999 | US5998639 Sulfatation of estrogen mixtures |
| 12/02/1999 | WO1999045886A3 New contraceptive kit for monotherapy |
| 12/01/1999 | EP0740708A4 Design of drugs involving receptor-ligand-dna interactions |
| 11/30/1999 | US5994568 Estrenes for inducing hypothalamic effects |
| 11/24/1999 | EP0957921A1 METHOD OF PREVENTING NEURODEGENERATION AND COGNITIVE DYSFUNCTION USING 17$g(a)-DIHYDROEQUILENIN |
| 11/24/1999 | CN1046735C Steroids for treating menopausal complaints |
| 11/23/1999 | US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula |
| 11/23/1999 | US5989568 Treating wrinkles and fine lines |
| 11/17/1999 | EP0956022A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound |
| 11/16/1999 | CA2109946C Fragrance compositions and other compositions which contain human pheromones |
| 11/10/1999 | EP0954317A2 Use of 7 apha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 11/09/1999 | US5981543 Method of treating androgenic alopecia with 5α-reductase inhibitors |
| 11/02/1999 | US5977096 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 11/02/1999 | US5977095 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome |
| 10/26/1999 | US5972923 Methods and compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 10/21/1999 | WO1999052863A1 VITAMIN D DERIVATIVES SUBSTITUTED AT THE 2β-POSITION |
| 10/20/1999 | EP0643581B1 Ocular androgen therapy in sjögren's syndrome |
| 10/19/1999 | US5969168 Stimulate autonomic activity |
| 10/12/1999 | US5965552 Administering androsta-4,16-dien-3-ol for treating tension, reducing anxiety; administering to the vomeronasal organ of individual |
| 10/06/1999 | EP0946583A1 Bissteroidal compounds and their use for the preparation of chiral complexes |
| 10/05/1999 | US5962667 Pharmaco-gene delivery in human breast cancer cells |
| 09/29/1999 | EP0945135A2 Treatment of alzheimer's disease and modulation of immune system with Delta5-Androstenes |
| 09/29/1999 | EP0944644A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 09/28/1999 | US5958770 Glycoalkaloids |
| 09/23/1999 | WO1999047485A1 Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents |
| 09/23/1999 | WO1999047143A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 09/22/1999 | EP0943333A1 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
| 09/22/1999 | EP0943328A2 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 09/21/1999 | US5955622 Method for the preparation of steroid derivative ketal |
| 09/21/1999 | US5955455 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | WO1999045886A2 New contraceptive kit for monotherapy |
| 09/16/1999 | CA2323089A1 Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use |
| 09/16/1999 | CA2319765A1 New contraceptive kit |
| 09/15/1999 | EP0941039A1 Transdermal administration of ment |
| 09/14/1999 | US5952319 Controlling male fertility in mammal |
| 09/10/1999 | WO1999044621A1 Preventives/remedies for osteoporosis |
| 09/10/1999 | WO1999044616A1 Steroid derived antibiotics |
| 09/07/1999 | US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch |
| 08/31/1999 | CA2118030C Drug for increasing the level of testosterone in the body |
| 08/26/1999 | WO1999042108A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system |
| 08/26/1999 | CA2321498A1 Pharmaceutical preparations for the selectively supplementing oestrogen deficiency in the central nervous system |
| 08/25/1999 | EP0921774A4 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 08/19/1999 | WO1999041272A1 Method of purifying tall oil sterol |
| 08/19/1999 | CA2286627A1 Method of purifying tall oil sterol |
| 08/18/1999 | CN1044702C Ozonide reducing method |
| 08/17/1999 | US5939570 Estrenes for inducing hypothalamic effects |
| 08/11/1999 | EP0934745A1 Use of androsterone derivatives for inhibiting DNA binding of ap-1 and airway smooth muscle proliferation |
| 08/11/1999 | EP0934334A1 8(9)-dehydroestradiol derivatives |
| 08/11/1999 | CN1225568A Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 07/21/1999 | EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES |
| 07/20/1999 | US5925774 Estrenes for inducing hypothalamic effects |
| 07/20/1999 | US5925630 Neuroactive steroids of the androstane and pregnane series |
| 07/14/1999 | EP0928609A2 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/14/1999 | CN1222851A Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 07/13/1999 | US5922700 Kit for drug delivery of steroids |
| 07/08/1999 | WO1999033768A1 Materials for screening of combinatorial libraries |
| 07/07/1999 | CN1222159A 6,7-oxygenated steroids and uses related thereto |
| 07/06/1999 | US5919821 Plant extract |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 06/29/1999 | US5916578 Lipid composition containing a liquid crystal phase |
| 06/23/1999 | EP0924219A2 Novel estrenes for inducing hypothalamic effects |
| 06/23/1999 | EP0752861A4 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors |
| 06/22/1999 | US5914325 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 06/22/1999 | US5914324 6-Hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same |
| 06/22/1999 | CA2176370C The use of steroids having a phenolic a-ring structure for prophylaxis and therapy of radical-mediated cellular trauma |
| 06/16/1999 | EP0921774A1 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 06/15/1999 | US5912008 Laminated structure of backing layer, moisture and impermeable layer, tackifiers and permeation enhancer |
| 06/09/1999 | EP0921130A2 Steroid sulphatase inhibitors |
| 06/03/1999 | WO1999026962A1 Androgenic steroid compounds and a method of making and using the same |
| 06/03/1999 | CA2311448A1 Androgenic steroid compounds and a method of making and using the same |
| 06/01/1999 | US5908945 Copper compound and silyl reagent as catalysts |
| 06/01/1999 | US5908944 Copper compound catalyst |
| 05/26/1999 | EP0917534A2 6,7-oxygenated steroids and uses related thereto |
| 05/25/1999 | CA2011452C Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7,17)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one |